Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

Item

http://www.wikidata.org/entity/Q34550216

Q34550216

about

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma The evolving role of response-adapted PET imaging in Hodgkin lymphoma The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease The optimal use of bexarotene in cutaneous T-cell lymphoma Hodgkin lymphoma, version 2.2015.Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.Aortic stiffness increases upon receipt of anthracycline chemotherapy Role of chemotherapy in Hodgkin's lymphoma.Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.Pediatric lymphomas and histiocytic disorders of childhood Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future Lymphocyte Depleted Hodgkin's Lymphoma Presented with Haemolytic Anemia: A Case Report and Literature Review.Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.FDG-PET/CT based response-adapted treatment.SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma Hodgkin's lymphoma: molecular targets and novel treatment strategies.Treatment of cutaneous T-cell lymphoma with retinoids.FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up Minimizing late effects in children and adults with Hodgkin lymphoma - the beginning of the end for radiation therapy.Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas.

P2860

Q24236589-CB03C858-9F46-4F4F-B495-EB3507DC753C Q26750993-6B3A86B8-5734-4BF5-A2D2-B8C35F2194CF Q26858893-447F1723-8E62-4708-A9EB-A588F7E079CB Q28305252-BA659D7D-EBCC-4A89-B678-29A7989121A8 Q30769157-5E872A8D-3074-42C0-9D53-23E38971CE50 Q30937299-7D72A9C5-E824-432D-A02E-B5496FFD3A15 Q33561937-44B6081B-A9C6-458C-9258-45DF2245A7F0 Q33761103-1070D881-9760-482A-9BB5-615626559E1E Q34185759-6BFD8F98-6C12-4C19-B5C4-0365D8CED8FC Q34235785-1D4750E6-3C1C-4D19-9092-8D7AA61CF7E8 Q34473445-F50F823F-8C3C-4F81-9699-C1052491BE62 Q34475763-7574E99E-0D15-4679-9D28-591D7BB1E475 Q34495333-49892316-460C-41FC-8189-AAF161DA24C6 Q34501005-67852A3D-66AE-499B-AFDE-5B20DD4ED08E Q34605894-BCBD8A8D-2F43-4711-B978-ED2DEA627AC4 Q34610653-75C93AC2-2B27-4BFE-9DF7-47181BE657E2 Q34617599-3D567BA2-91C3-40D9-A3A0-9B659B8D1809 Q35029924-C1D1FA74-1F87-4372-8185-98A7A246425B Q35038832-DB399E9B-EFD3-476F-99FA-88FC98A8564E Q35038852-1737E8B1-11DB-457E-8F32-B9A1A3A4918D Q35232042-8EFAC061-73CB-4684-8A8E-E7B70006FAA3 Q35986604-E9AA57E3-B66B-493B-A0F4-758BDFE14EF2 Q36135751-CDD32FCF-A21A-4C0A-8982-B9AF9F2EDE8F Q36286595-D538B59E-B59C-42CC-A1A2-6237608FF1B7 Q36400264-FD9BECF2-7605-4266-8AD5-08164051DBB5 Q36440046-3DBD8306-605B-4771-ABDF-FCDB4B0E0643 Q36464310-2C57C799-E324-44CC-88AD-0B30B851FBAB Q36479283-A5619EDD-B308-4637-947A-162396B07013 Q36572545-97616D00-C3E1-4C5B-BECA-1F8E4DADC62F Q36609811-B5EB48C5-8789-48E2-B840-27CC01ADD6F2 Q36838768-3408A3C8-58A3-467F-9305-2CA10F28D3B1 Q36939926-39601D1A-9245-436A-BAB2-A5376CE86CC5 Q37146056-00EBB17D-7C99-41D3-9F81-D48382510229 Q37157419-DDA20DA3-B3D8-49E7-8F2F-A2F5822E3F9A Q37304122-B4AD797D-7CD6-4592-943C-D8904017C0FC Q37383554-CB40073D-EB0D-4B06-A74D-B7A866E77EA0 Q37563122-4C15F530-3BD7-413B-B5D9-F38EDCBB6181 Q37598106-01EA117F-DFDF-4A4F-BC09-53C34987B60E Q37644025-6B98100A-6013-4EEE-9019-13D98F9C49B0 Q37775633-66FDEBE9-F0D9-4603-827A-24F962071959

P2860

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

Item

http://www.wikidata.org/entity/Q34550216

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu